EP300 and precursor B-cell acute lymphoblastic leukemia: Our recent study showed that depletion of IL3RA completely abolished the growth advantage conferred by EP300-ZNF384 in B-ALL cells and impaired the engraftment of EP300-ZNF384-positive B-ALL cells in mice.